{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:07:54Z","timestamp":1790154474194,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206194\/Z\/17\/Z"],"award-info":[{"award-number":["206194\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013996","name":"Global Health Innovative Technology Fund","doi-asserted-by":"publisher","award":["T2024-268"],"award-info":[{"award-number":["T2024-268"]}],"id":[{"id":"10.13039\/501100013996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-04096"],"award-info":[{"award-number":["INV-04096"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","award":["RD-18-0005"],"award-info":[{"award-number":["RD-18-0005"]}],"id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mib.2026.102792","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:59:00Z","timestamp":1783601940000},"page":"102792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Molecular mechanisms underlying resistance to antimalarial compounds"],"prefix":"10.1016","volume":"92","author":[{"given":"Mukul","family":"Rawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4973-0915","authenticated-orcid":false,"given":"Marcus CS","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2026.102792_bib1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.trstmh.2008.11.002","article-title":"The evolution of drug-resistant malaria","volume":"103","author":"Plowe","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.mib.2026.102792_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-019-1795-x","article-title":"Structure and drug resistance of the Plasmodium falciparum transporter PfCRT","volume":"576","author":"Kim","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.mib.2026.102792_bib3","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/febs.14127","article-title":"Combating multidrug-resistant Plasmodium falciparum malaria","volume":"284","author":"Thu","year":"2017","journal-title":"FEBS J"},{"key":"10.1016\/j.mib.2026.102792_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mib.2026.102792_sbref5","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-72834-6","article-title":"Cellular and molecular basis of PfCoronin function in artemisinin resistance in Plasmodium falciparum","author":"Ullah","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102792_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01542-19","article-title":"Modification of pfap2mu and pfubp1 markedly reduces ring-stage susceptibility of Plasmodium falciparum to artemisinin in vitro","volume":"64","author":"Henrici","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2026.102792_sbref7","article-title":"Epigenetically conferred ring-stage survival in Plasmodium falciparum against artemisinin treatment","volume":"16","author":"Yu","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102792_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-018-2532-x","article-title":"A single nucleotide polymorphism in the Plasmodium falciparum atg18 gene associates with artemisinin resistance and confers enhanced parasite survival under nutrient deprivation","volume":"17","author":"Breglio","year":"2018","journal-title":"Malar J"},{"key":"10.1016\/j.mib.2026.102792_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev-micro-020518-115546","article-title":"Molecular mechanisms of drug resistance in Plasmodium falciparum malaria","volume":"74","author":"Wicht","year":"2020","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.mib.2026.102792_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00109-24","article-title":"Artemisinin-resistant malaria","volume":"37","author":"White","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mib.2026.102792_bib11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.pt.2024.09.002","article-title":"Peeling the onion: how complex is the artemisinin resistance genetic trait of malaria parasites?","volume":"40","author":"Kucharski","year":"2024","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.mib.2026.102792_sbref12","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk9893","article-title":"Systematic in vitro evolution in Plasmodium falciparum reveals key determinants of drug resistance","volume":"386","author":"Luth","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.mib.2026.102792_bib13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.105544","article-title":"Understanding the global rise of artemisinin resistance: insights from over 100,000 Plasmodium falciparum samples","volume":"14","author":"Balmer","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.mib.2026.102792_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102792_bib15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.mib.2026.102792_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-015-0581-y","article-title":"PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs","volume":"14","author":"van der Velden","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.mib.2026.102792_bib17","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1093\/jac\/dku125","article-title":"Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east Myanmar","volume":"69","author":"Gupta","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mib.2026.102792_bib18","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/s41564-023-01377-z","article-title":"Chloroquine resistance evolution in Plasmodium falciparum is mediated by the putative amino acid transporter AAT1","volume":"8","author":"Amambua-Ngwa","year":"2023","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.mib.2026.102792_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1126\/science.aan4472","article-title":"Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics","volume":"359","author":"Cowell","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.mib.2026.102792_bib20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.chembiol.2021.06.006","article-title":"The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance","volume":"29","author":"Murithi","year":"2022","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.mib.2026.102792_sbref21","article-title":"Plasmodium falciparum quinine resistance is multifactorial and includes a role for the drug\/metabolite transporters PfCRT and DMT1","author":"Kanai","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.mib.2026.102792_bib22","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/jac\/dkab219","article-title":"Cross-resistance of the chloroquine-derivative AQ-13 with amodiaquine in Cambodian Plasmodium falciparum isolates","volume":"76","author":"Nardella","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mib.2026.102792_sbref23","series-title":"Collateral Hypersensitivity between ZY19489 and Piperaquine Neutralizes PfCRT-mediated Drug Efflux and Plasmodium falciparum Resistance","author":"Okombo","year":"2026"},{"key":"10.1016\/j.mib.2026.102792_sbref24","article-title":"Deaggregation of mutant Plasmodium yoelii de-ubiquitinase UBP1 alters MDR1 localization to confer multidrug resistance","volume":"15","author":"Xu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102792_bib25","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"Rottmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.mib.2026.102792_bib26","doi-asserted-by":"crossref","first-page":"E5455","DOI":"10.1073\/pnas.1414221111","article-title":"(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium","volume":"111","author":"Jimenez-Diaz","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2026.102792_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33403-9","article-title":"A G358S mutation in the Plasmodium falciparum Na(+) pump PfATP4 confers clinically-relevant resistance to cipargamin","volume":"13","author":"Qiu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102792_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1126\/science.aax4735","article-title":"A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites","volume":"367","author":"Birnbaum","year":"2020","journal-title":"Science"},{"issue":"50","key":"10.1016\/j.mib.2026.102792_bib29","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1073\/pnas.1812317115","article-title":"Mutations in Plasmodium falciparum actin-binding protein coronin confer reduced artemisinin susceptibility","volume":"115","author":"Demas","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2026.102792_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-27417-6","article-title":"Protein KIC5 is a novel regulator of artemisinin stress response in the malaria parasite Plasmodium falciparum","volume":"13","author":"Simmons","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.mib.2026.102792_sbref31","doi-asserted-by":"crossref","DOI":"10.1126\/science.adm7966","article-title":"A kalihinol analog disrupts apicoplast function and vesicular trafficking in P. falciparum malaria","volume":"385","author":"Chahine","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.mib.2026.102792_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg6013","article-title":"The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance","volume":"13","author":"Murithi","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mib.2026.102792_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02918-19","article-title":"The Plasmodium falciparum artemisinin susceptibility-associated AP-2 adaptin mu subunit is clathrin independent and essential for schizont maturation","volume":"11","author":"Henrici","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.mib.2026.102792_bib34","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.bbamcr.2015.08.007","article-title":"Eps15 homology domain containing protein of Plasmodium falciparum (PfEHD) associates with endocytosis and vesicular trafficking towards neutral lipid storage site","volume":"1853","author":"Thakur","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mib.2026.102792_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00696-16","article-title":"Mutations in the Plasmodium falciparum cyclic amine resistance locus (PfCARL) confer multidrug resistance","volume":"7","author":"LaMonte","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.mib.2026.102792_bib36","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1021\/acsinfecdis.6b00025","article-title":"Plasmodium falciparum cyclic amine resistance locus (PfCARL), a resistance mechanism for two distinct compound classes","volume":"2","author":"Magistrado","year":"2016","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.mib.2026.102792_bib37","article-title":"Plasmodium SEY1 is a novel druggable target that contributes to imidazolopiperazine mechanism of action","author":"Winzeler","year":"2024","journal-title":"Res Sq"},{"key":"10.1016\/j.mib.2026.102792_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03239-21","article-title":"A phosphoinositide-binding protein acts in the trafficking pathway of hemoglobin in the malaria parasite Plasmodium falciparum","volume":"13","author":"Mukherjee","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.mib.2026.102792_sbref39","article-title":"A novel locus associated with decreased susceptibility of Plasmodium falciparum to lumefantrine and dihydroartemisinin has emerged and spread in Uganda","author":"Niare","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.mib.2026.102792_sbref40","article-title":"A Plasmodium falciparum PX1 haplotype is associated with reduced susceptibility to artemisinin and lumefantrine","author":"Bower-Lepts","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.mib.2026.102792_bib41","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/bcp.70000","article-title":"First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367","volume":"91","author":"Kuemmerle","year":"2025","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.mib.2026.102792_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36921-2","article-title":"Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation","volume":"14","author":"Bopp","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102792_bib43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature12782","article-title":"Targeting Plasmodium PI(4)K to eliminate malaria","volume":"504","author":"McNamara","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.mib.2026.102792_bib44","article-title":"UCT943, a next-generation Plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria","volume":"62","author":"Brunschwig","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2026.102792_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mib.2026.102792_sbref46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013645","article-title":"PfATP2 is a flippase on the Plasmodium falciparum surface that is important for growth and influences parasite sensitivity to antiplasmodial compounds","volume":"21","author":"Qiu","year":"2025","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2026.102792_sbref47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012216","article-title":"Quinoxaline-based anti-schistosomal compounds have potent anti-plasmodial activity","volume":"21","author":"Rawat","year":"2025","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2026.102792_bib48","doi-asserted-by":"crossref","first-page":"19429","DOI":"10.1074\/jbc.M113.468371","article-title":"An epigenetic antimalarial resistance mechanism involving parasite genes linked to nutrient uptake","volume":"288","author":"Sharma","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mib.2026.102792_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02021-19","article-title":"A histone methyltransferase inhibitor can reverse epigenetically acquired drug resistance in the malaria parasite Plasmodium falciparum","volume":"64","author":"Chan","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2026.102792_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.98221","article-title":"A drug repurposing approach reveals targetable epigenetic pathways in Plasmodium vivax hypnozoites","volume":"13","author":"Maher","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.mib.2026.102792_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79539-w","article-title":"Histone acetyltransferase PfGCN5 regulates stress responsive and artemisinin resistance related genes in Plasmodium falciparum","volume":"11","author":"Rawat","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.mib.2026.102792_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00577-23","article-title":"Plasmodium falciparum GCN5 plays a key role in regulating artemisinin resistance-related stress responses","volume":"67","author":"Lucky","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2026.102792_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02377-23","article-title":"PfHDAC1 is an essential regulator of P. falciparum asexual proliferation and host cell invasion genes with a dynamic genomic occupancy responsive to artemisinin stress","volume":"15","author":"Kanyal","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.mib.2026.102792_sbref54","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/s41564-024-01664-3","article-title":"tRNA modification reprogramming contributes to artemisinin resistance in Plasmodium falciparum","volume":"9","author":"Small-Saunders","year":"2024","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.mib.2026.102792_bib55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.chembiol.2021.07.010","article-title":"Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention","volume":"29","author":"Summers","year":"2022","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.mib.2026.102792_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01026-25","article-title":"Acetyl-CoA synthetase mutations affect the susceptibility of Plasmodium falciparum to antimalarial drugs","volume":"13","author":"Zhao","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.mib.2026.102792_bib57","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.chom.2020.02.005","article-title":"Dual plasmepsin-targeting antimalarial agents disrupt multiple stages of the malaria parasite life cycle","volume":"27","author":"Favuzza","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mib.2026.102792_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.106061","article-title":"MK-7602: a potent multi-stage dual-targeting antimalarial","volume":"123","author":"Favuzza","year":"2026","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mib.2026.102792_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14240","article-title":"Esterase mutation is a mechanism of resistance to antimalarial compounds","volume":"8","author":"Istvan","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102792_bib60","article-title":"Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase","volume":"15","author":"Xie","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102792_bib61","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.abn0611","article-title":"Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy","volume":"376","author":"Xie","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.mib.2026.102792_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-44077-2","article-title":"Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors","volume":"14","author":"Hsu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102792_bib63","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.chembiol.2024.07.001","article-title":"Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria","volume":"31","author":"Lawong","year":"2024","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.mib.2026.102792_bib64","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.chembiol.2023.03.002","article-title":"Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome","volume":"30","author":"Deni","year":"2023","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.mib.2026.102792_bib65","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.chembiol.2023.04.006","article-title":"Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance","volume":"30","author":"Zhan","year":"2023","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.mib.2026.102792_sbref66","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.chembiol.2025.09.007","article-title":"Disruption of P. falciparum amino acid transporter elevates intracellular proline and induces resistance to Prolyl-tRNA synthetase inhibitors","volume":"32","author":"Bopp","year":"2025","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.mib.2026.102792_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01193-18","article-title":"Suppression of drug resistance reveals a genetic mechanism of metabolic plasticity in malaria parasites","volume":"9","author":"Guggisberg","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.mib.2026.102792_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010803","article-title":"GAPDH mediates drug resistance and metabolism in Plasmodium falciparum malaria parasites","volume":"18","author":"Jezewski","year":"2022","journal-title":"PLoS Pathog"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136952742600086X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136952742600086X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:37:12Z","timestamp":1790152632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S136952742600086X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":68,"alternative-id":["S136952742600086X"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2026.102792","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms underlying resistance to antimalarial compounds","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mib.2026.102792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102792"}}